Roche to pay $7.1B to acquire Telavant

The latest stories trending on MedCity News.

Editor's Pick

Top Story Roche to Pay $7.1B to Get Contender in Tight Inflammatory Bowel Disease Race Roche's Telavant acquisition comes as the Roivant Sciences subsidiary prepares its main asset for Phase 3 testing in ulcerative colitis. The antibody drug candidate blocks a novel target for inflammation and fibrosis that's also the focus of clinical-stage programs of other big pharma companies. Sponsored Content Hospitals Need to Cultivate a Culture of Informed Awareness Presented by Care Logistics and MedCity News In an upcoming webinar, learn how informed awareness can help hospitals overcome their most challenging operational challenges to simultaneously improve efficiency, staff engagement and satisfaction, quality of care, and profitability. Sign up today and join the conversation! Will We See You in Dallas? You can still get tickets. Don't miss this great boutique event on Thursday at Pegasus Park in Dallas. Get My Ticket

Featured News

Time Is Running Out to Register for MedCity INVEST Digital Health in Dallas on October 26 The INVEST Digital Health conference in Dallas, a collaboration between MedCity News and the Health Wildcatters accelerator, spotlights a wide range of hot topics in digital health, a startup pitch contest focused on femtech, and networking opportunities with investors and healthcare stakeholders. Register today! Proliferation of Benefits Providers Highlights Greater Need for Integration and Navigation, Survey Finds Consultants are spending more time evaluating vendors and parsing options in growing areas such as mental health, inclusive family planning and chronic care, according to "The 2023 Benefit Consultant Sentiment Index" conducted over the summer in partnership with Quantum Health. Forget Fair-Weather Healthcare: Disruptors of This Industry Are Already in It Companies built for other businesses are attempting to offroad their skills into a brand new field. These fairweather healthcare players are unprepared for the terrain. Meanwhile, the true disruptors of this industry are already in it. Abivax Adds $236M to Show Its Anti-Inflammatory Med Can Stand Apart in Crowded Field Abivax pulled off stock market deals in the U.S. and Europe that infuse the biotech with capital to continue clinical development of a small molecule for inflammation that's differentiated from biologic therapies. In other biotech IPO news, Cargo Therapeutics and Invea Therapeutics both filed paperwork to go public. LLMs Can Perpetuate Harmful Ideas About Race-Based Medicine, Study Shows A new study led by Stanford researchers tested four commercially available LLMs and found that they all could potentially cause harm by breeding inaccurate, racist information. For example, all models tried to justify race-based medicine when asked questions about calculating patients' kidney function and lung capacity — two areas where race-based medicine practices used to be common but have since been scientifically refuted. Execs Weigh In on the Gaps in Suicide Prevention There are several gaps in suicide prevention, including a lack of screening and access to care. During a recent panel discussion at HLTH 2023, execs detailed what gaps need to be filled. Weight Loss Startup Calibrate Is Changing Hands Weight loss company Calibrate — which sells a program combining GLP-1 drugs with personalized metabolic health coaching — announced a legal restructuring of its business. The startup, which had two major rounds of layoffs this year, has struggled in recent months amid GLP-1 drug shortages and mounting user complaints. 2.3M People Would Gain Coverage If Remaining 10 States Expanded Medicaid If the remaining 10 states expanded Medicaid, uninsured rates would greatly drop for women of reproductive age, non-Hispanic Black adults and young adults, a new Urban Institute report found.

Resources

Heard at HLTH: Healthcare Execs Share Perspectives on AI, Virtual Health and Value-based Care As part of the Heard at HLTH video series, MedCity News Editor in Chief Arundhati Parmar and Senior Reporter Katie Adams interviewed healthcare executives about innovations in health tech at HLTH 2023 in Las Vegas earlier this month. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe